We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sanofi, Novo Spar In Insulin Pen Patent Suit—Again

Law360 (October 26, 2007, 12:00 AM EDT) -- Sanofi-Aventis has bulwarked its defenses against Novo Nordisk A/S and stepped up its demands for relief in their insulin pen spat with a dozen counterclaims, citing a licensing deal it said...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.